349 related articles for article (PubMed ID: 12803853)
21. Resistance of infection by Plasmodium vivax to chloroquine in Bolivia.
Añez A; Moscoso M; Laguna Á; Garnica C; Melgar V; Cuba M; Gutierrez S; Ascaso C
Malar J; 2015 Jul; 14():261. PubMed ID: 26126708
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of malaria in Aligarh.
Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia.
Ketema T; Bacha K; Birhanu T; Petros B
Malar J; 2009 Jul; 8():177. PubMed ID: 19642976
[TBL] [Abstract][Full Text] [Related]
24. Resurgence of malaria and drug resistance in Plasmodium falciparum and vivax species in Bombay.
Sorabjee JS
J Assoc Physicians India; 1996 Jan; 44(1):71. PubMed ID: 8773108
[No Abstract] [Full Text] [Related]
25. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Shawa Robit Health Care Centre, North-East Ethiopia.
Seifu S; Zeynudin A; Zemene E; Suleman S; Biruksew A
Acta Trop; 2017 Jul; 171():44-51. PubMed ID: 28300558
[TBL] [Abstract][Full Text] [Related]
27. Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.
Potkar CN; Kshirsagar NA; Kathuria R
J Assoc Physicians India; 1995 May; 43(5):336-8. PubMed ID: 9081964
[TBL] [Abstract][Full Text] [Related]
28. Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
Thanh PV; Hong NV; Van NV; Louisa M; Baird K; Xa NX; Peeters Grietens K; Hung le X; Duong TT; Rosanas-Urgell A; Speybroeck N; D'Alessandro U; Erhart A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7411-9. PubMed ID: 26392501
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia.
Maguire JD; Sumawinata IW; Masbar S; Laksana B; Prodjodipuro P; Susanti I; Sismadi P; Mahmud N; Bangs MJ; Baird JK
Lancet; 2002 Jul; 360(9326):58-60. PubMed ID: 12114045
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine sensitivity of Plasmodium vivax in Thailand.
Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern.
Valecha N; Joshi H; Eapen A; Ravinderan J; Kumar A; Prajapati SK; Ringwald P
Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):831-7. PubMed ID: 16513151
[TBL] [Abstract][Full Text] [Related]
32. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries.
Naing C; Aung K; Win DK; Wah MJ
Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):695-705. PubMed ID: 20850161
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium falciparum gametocytaemia with chloroquine chemotherapy in persistent malaria in an endemic area of India.
Kar PK; Dua VK; Gupta NC; Gupta A; Dash AP
Indian J Med Res; 2009 Mar; 129(3):299-304. PubMed ID: 19491423
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia.
Assefa M; Eshetu T; Biruksew A
Malar J; 2015 Nov; 14():458. PubMed ID: 26577669
[TBL] [Abstract][Full Text] [Related]
38. Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys.
Obaldia N; Milhous WK; Kyle DE
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941642
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine resistant malaria in children.
Memon IA; Kanth N; Murtaza G
J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043
[TBL] [Abstract][Full Text] [Related]
40. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
